Clinical Study

Randomized, Double-Blind, and Placebo-Controlled Trial of Clenbuterol in Denervated Muscle Atrophy

Table 1

General characteristics of patients who completed trial.

EMGBiopsy
ClenbuterolPlaceboClenbuterolPlacebo

Number15
M = 13, F = 2
17
M = 14, F = 3
𝑃 value12
M = 11, F = 1
13
M = 12, F = 1
𝑃 value

Age, y 2 7 . 4 ± 1 . 6 2 4 . 5 ± 2 . 5 >0.05 2 8 . 3 ± 3 . 1 2 7 . 3 ± 1 . 6 >0.05
Denervation period before trial, m 4 . 8 ± 0 . 7 6 . 5 ± 1 . 6 >0.05 4 . 8 ± 1 . 0 4 . 7 ± 0 . 9 >0.05

Figures are means ± standard errors; y: years, m: months.